Finance

Lists
317450:KRX
Myung In Pharm Co Ltd
42 150,00 KRW
+1,93%
(+800,00) 1D
19-окт., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 317450...
Open
40 450 KRW
High
42 150 KRW
Low
40 450 KRW
Mkt. cap
615,39 млд
Avg. vol.
11,16 миң
Volume
9,39 миң
Dividend
2,37%
Quarterly dividend
250 KRW
Ex-dividend date
2026-ж., 28-авг.
P/E ratio
4,46
52-wk high
97 400 KRW
52-wk low
39 100 KRW
EPS
9 453 KRW
Shares outstanding
14,60 млн
Open
40 450 KRW
High
42 150 KRW
Low
40 450 KRW
Mkt. cap
615,39 млд
Avg. vol.
11,16 миң
Volume
9,39 миң
Dividend
2,37%
Quarterly dividend
250 KRW
Ex-dividend date
2026-ж., 28-авг.
P/E ratio
4,46
52-wk high
97 400 KRW
52-wk low
39 100 KRW
EPS
9 453 KRW
Shares outstanding
14,60 млн
News stories
From web sources and news partners
About Myung In Pharm Co Ltd
CEOLee Hang Myung | Kim Jae-hyuk | Ko Dong-kyu
Employees-
Foundedапр. 1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
72,70 млд
72,09 млд
72,14 млд
76,11 млд
Cost of goods sold
28,31 млд
28,44 млд
27,56 млд
27,73 млд
Cost of revenue
28,31 млд
28,44 млд
27,56 млд
27,73 млд
Research and development expenses
1,37 млд
1,42 млд
1,10 млд
2,20 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,79 млд
17,14 млд
17,47 млд
17,72 млд
Operating expense
22,48 млд
19,98 млд
19,47 млд
20,77 млд
Total operating expenses
50,78 млд
48,42 млд
47,03 млд
48,49 млд
Operating income
21,91 млд
23,67 млд
25,11 млд
27,61 млд
Other non operating income
206,58 млн
15,97 млн
446,90 млн
93,97 млн
EBT including unusual items
24,11 млд
26,79 млд
30,04 млд
31,82 млд
EBT excluding unusual items
24,11 млд
26,77 млд
30,04 млд
31,82 млд
Income tax expense
5,56 млд
3,53 млд
7,31 млд
7,50 млд
Effective tax rate
23,05%
13,20%
24,32%
23,57%
Other operating expenses
614,50 млн
533,43 млн
318,66 млн
288,62 млн
Net income
18,55 млд
23,25 млд
22,73 млд
24,32 млд
Net profit margin
25,51%
32,25%
31,51%
31,96%
Earnings per share
-
-
-
-
Interest and investment income
1,72 млд
3,26 млд
3,55 млд
3,54 млд
Interest expense
-57,80 млн
-55,11 млн
-54,73 млн
-56,49 млн
Net interest expenses
1,67 млд
3,20 млд
3,50 млд
3,48 млд
Depreciation and amortization charges
636,54 млн
648,53 млн
612,05 млн
617,68 млн
EBITDA
24,47 млд
26,18 млд
27,62 млд
30,19 млд
Gain or loss from assets sale
904,00 миң
-21,89 млн
-
-
AI content may include mistakes. Learn more
Google колдонмолору